Parkinson’s disease (PD) is the second-most common neurodegenerative disorder after Alzheimer’s disease and the fastest-growing neurodegenerative disease. A 2021 research study showed that Photobiomodulation (PBM) resulted in significant improvements in patients’ mobility, cognition, dynamic balance, and fine motor skills and could be a safe and potentially effective option, with no side effects observed. Improvements were maintained for as long as PBM continued, for up to one year in a neurodegenerative disease where decline is typically expected. Home use of PBM by the person themselves or with the help of a caregiver might be an effective option for many PD symptoms.